On Demand Webinars
Leveraging Instrumentation to Accelerate Release Testing & Minimize Human Input
Presented by Therese Choquette, Head of Analytical and Translational Sciences at Tigen Pharma and Zhong Yu, Snr. Business Development Manager at Axion BioSystems, Allen L. Burgenson, Global Subject Matter Expert, Testing Solutions at Lonza, Félix Montero-Julian, Scientific Director of Pharma Quality Control at bioMérieux
16th January 2025
Current Status and Overview of the Rapid Microbiological Methods and Endotoxin Microbiology USP Chapters under Development
Presented by Jay Bolden, Senior Director, Eli Lilly and Company Global Quality Laboratories, Dr David Roesti, PhD. Microbiologist/Facilitator QA/QC at Novartis Pharma AG, Veronika Wills, Manager, Technical Services at Associates of Cape Cod, Inc, Nicola Reid, Associate Director of Endotoxin Products at Charles River, Lamin Jallow, Microbiology Technology Specialist at Merck KGaA and Félix Montero-Julian, Scientific Director of Pharma Quality Control at bioMérieux
04th December 2024
Process Equipment Related Leachable Compounds – 3 Case Studies
Presented by Dr. Tarja Nurmi, Senior Expert, Extractables & Leachables at Bayer, Pieter Van Wouwe, Scientific expert at Nelson Labs
14th November 2024
Achieving Fully Continuous End-to-End Processing
Presented by Jon Coffman, Executive Director of Bioprocess Technology and Engineering at AstraZeneca
07th November 2024
Evaluating Analytical Strategies to Quantify Capsid Titre: Towards a Platform-Method Approach to Accelerate AAV Drug Product Development
Presented by Dr. Marilia Barros, PhD, Principal Scientist Biologics & Gene Therapy Drug Product Development at Regeneron and Dr. Matt Ranaghan, Senior Applications Scientist, at Refeyn
30th October 2024
The Factory of the Future
Presented by Robert Dream, Principal Consultant at HDR Company LLC
29th October 2024
Defining Patient-Centric Specification in a Risk-Based Control System
Presented by Gerald Gellermann, Scientific Officer at Novartis
22nd October 2024
Downstream Platform Process Development for AAV viral vectors; Challenges and Opportunities
Presented by Presented by Parag Kumthekar, Lead Gene Therapy Downstream Process Development at UCB
02nd October 2024
Adventitious Agent Testing For MMV: How Much Do We Really Know?
Presented by Maria Farcet, Head of Cell Culture, Virus Models & Serology in the Global Pathogen Safety / Global Quality team at Takeda, Amina Cherif Louazani, PhD, Viral Safety Manager at PathoQuest and Dr. Denise Teber, Scientific Expert of the PCR department at Charles River Laboratories
01st October 2024
Medical Device Chemical Toxicological Risk Assessments: Applying Toxicological Principles to Meet the Challenge
Presented by Alan Hood, Toxicologist at the US FDA/CDRH/OPEQ and Sandi Schaible, Executive Director, Analytical Chemistry and Regulatory Toxicology at WuXi AppTec
23rd September 2024